cached image

Christopher Oermann, M.D. - Publications

Affiliations: 
Children's Mercy Hospital, Kansas City, KS, United States 

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tiddens HA, De Boeck K, Clancy JP, Fayon M, H G M A, Bresnik M, Derchak A, Lewis SA, Oermann CM. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 111-9. PMID 25091537 DOI: 10.1016/J.Jcf.2014.06.003  0.68
2014 Mogayzel PJ, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Annals of the American Thoracic Society. 11: 1640-50. PMID 25549030 DOI: 10.1513/Annalsats.201404-166Oc  0.68
2013 Assael BM, Pressler T, Bilton D, Fayon M, Fischer R, Chiron R, LaRosa M, Knoop C, McElvaney N, Lewis SA, Bresnik M, Montgomery AB, Oermann CM. Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 130-40. PMID 22985692 DOI: 10.1016/j.jcf.2012.07.006  0.68
2012 Castro-Elias WA, Singh S, Hiatt PW, Oermann CM, Moore RH. Efficacy of ivacaftor in a child with cystic fibrosis, end-stage lung disease, and cepacia syndrome Pediatric, Allergy, Immunology, and Pulmonology. 25: 231-233. DOI: 10.1089/ped.2012.0193  0.68
2011 Oermann CM, McCoy KS, Retsch-Bogart GZ, Gibson RL, McKevitt M, Montgomery AB. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI). The Journal of Antimicrobial Chemotherapy. 66: 2398-404. PMID 21784781 DOI: 10.1093/Jac/Dkr303  0.68
2011 Accurso FJ, Moss RB, Wilmott RW, Anbar RD, Schaberg AE, Durham TA, Ramsey BW. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function. American Journal of Respiratory and Critical Care Medicine. 183: 627-34. PMID 21169471 DOI: 10.1164/Rccm.201008-1267Oc  0.68
2010 Flume PA, Mogayzel PJ, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. American Journal of Respiratory and Critical Care Medicine. 182: 298-306. PMID 20675678 DOI: 10.1164/Rccm.201002-0157Oc  0.68
2010 Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS, Montgomery AB, Cooper PJ. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatric Pulmonology. 45: 1121-34. PMID 20672296 DOI: 10.1002/Ppul.21301  0.68
2010 Sontag MK, Quittner AL, Modi AC, Koenig JM, Giles D, Oermann CM, Konstan MW, Castile R, Accurso FJ. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatric Pulmonology. 45: 291-300. PMID 20146387 DOI: 10.1002/Ppul.21179  0.68
2009 Retsch-Bogart GZ, Quittner AL, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, Cooper PJ. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest. 135: 1223-32. PMID 19420195 DOI: 10.1378/Chest.08-1421  0.68
2008 McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 178: 921-8. PMID 18658109 DOI: 10.1164/Rccm.200712-1804Oc  0.68
2008 Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatric Pulmonology. 43: 47-58. PMID 18041081 DOI: 10.1002/Ppul.20736  0.68
2007 Garcia DF, Hiatt PW, Jewell A, Schoonover SL, Cron SG, Riggs M, Grace S, Oermann CM, Piedra PA. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatric Pulmonology. 42: 66-74. PMID 17123316 DOI: 10.1002/Ppul.20546  0.68
2006 Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Daines C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL. Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Pediatric Pulmonology. 41: 656-65. PMID 16703579 DOI: 10.1002/Ppul.20429  0.68
2006 Borowitz D, Goss CH, Stevens C, Hayes D, Newman L, O'Rourke A, Konstan MW, Wagener J, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann CM, Aitken ML, Mahl TC, et al. Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. Pancreas. 32: 258-63. PMID 16628080 DOI: 10.1097/01.Mpa.0000202952.10612.21  0.68
2005 Oermann CM, Al-Salmi Q, Seilheimer DK, Finegold M, Tatevian N. Mucinous cystadenocarcinoma of the pancreas in an adolescent with cystic fibrosis. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 8: 391-6. PMID 16010483 DOI: 10.1007/S10024-005-4114-5  0.68
2004 Buyse IM, McCarthy SE, Lurix P, Pace RP, Vo D, Bartlett GA, Schmitt ES, Ward PA, Oermann C, Eng CM, Roa BB. Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 6: 426-30. PMID 15371908 DOI: 10.1097/01.Gim.0000139508.61701.Bd  0.68
2003 Piedra PA, Cron SG, Jewell A, Hamblett N, McBride R, Palacio MA, Ginsberg R, Oermann CM, Hiatt PW. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 21: 2448-60. PMID 12744878 DOI: 10.1016/S0264-410X(03)00098-7  0.68
2003 Schultz KD, Oermann CM. Treatment of cast bronchitis with low-dose oral azithromycin. Pediatric Pulmonology. 35: 139-43. PMID 12526076 DOI: 10.1002/ppul.10196  0.68
2002 Berlinski A, Fan LL, Kozinetz CA, Oermann CM. Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. Pediatric Pulmonology. 34: 297-303. PMID 12205571 DOI: 10.1002/Ppul.10159  0.68
2002 Kanu A, Oermann CM, Malicki D, Wagner M, Langston C. Pulmonary lipoblastoma in an 18-month-old child: a unique tumor in children. Pediatric Pulmonology. 34: 150-4. PMID 12112785 DOI: 10.1002/ppul.10144  0.68
2001 Oermann CM. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future. Current Opinion in Investigational Drugs (London, England : 2000). 2: 900-6. PMID 11757788  0.68
2001 Oermann CM, Sockrider MM, Giles D, Sontag MK, Accurso FJ, Castile RG. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study. Pediatric Pulmonology. 32: 372-7. PMID 11596162 DOI: 10.1002/Ppul.1146  0.68
2000 Oermann CM. Fertility in patients with cystic fibrosis. Chest. 118: 893-4. PMID 11035652  0.68
2000 Janahi IA, Maciejewski SR, Teran JM, Oermann CM. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease. Pediatric Pulmonology. 30: 257-9. PMID 10973044 DOI: 10.1002/1099-0496(200009)30:3<257::Aid-Ppul10>3.0.Co;2-R  0.68
2000 Oermann CM, Swank PR, Sockrider MM. Validation of an instrument measuring patient satisfaction with chest physiotherapy techniques in cystic fibrosis. Chest. 118: 92-7. PMID 10893365 DOI: 10.1378/Chest.118.1.92  0.68
2000 Oermann CM, Panesar KS, Langston C, Larsen GL, Menendez AA, Schofield DE, Cosio C, Fan LL. Pulmonary infiltrates with eosinophilia syndromes in children. The Journal of Pediatrics. 136: 351-8. PMID 10700692 DOI: 10.1067/Mpd.2000.103350  0.68
2000 Elidemir O, Maciejewski SR, Oermann CM. Falsely elevated serum tobramycin concentrations in cystic fibrosis patients treated with concurrent intravenous and inhaled tobramycin. Pediatric Pulmonology. 29: 43-5. PMID 10613786 DOI: 10.1002/(Sici)1099-0496(200001)29:1<43::Aid-Ppul8>3.0.Co;2-G  0.68
1999 Murry DJ, Oermann CM, Ou CN, Rognerud C, Seilheimer DK, Sockrider MM. Pharmacokinetics of ibuprofen in patients with cystic fibrosis. Pharmacotherapy. 19: 340-5. PMID 10221372 DOI: 10.1592/Phco.19.4.340.30944  0.68
1999 Oermann CM, Sockrider MM, Konstan MW. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. Chest. 115: 1053-8. PMID 10208207 DOI: 10.1378/Chest.115.4.1053  0.68
1999 Murry DJ, Kearns GL, Oermann C, Gaedigk A, Sockrider M, Seilheimer DK, Leeder JS. CYP2C9 genotype and ibuprofen (IBU) pharmacokinetics (PK) in cystic fibrosis (CF) Clinical Pharmacology and Therapeutics. 65: 140. DOI: 10.1016/S0009-9236(99)80092-7  0.68
1997 Oermann C, Sockrider MM, Langston C. Severe necrotizing pneumonitis in a child with Mycoplasma pneumoniae infection. Pediatric Pulmonology. 24: 61-5. PMID 9261856 DOI: 10.1002/(Sici)1099-0496(199707)24:1<61::Aid-Ppul11>3.0.Co;2-8  0.68
1997 Oermann CM, Starke JR, Seilheimer DK. Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis. The Pediatric Infectious Disease Journal. 16: 257-9. PMID 9041615 DOI: 10.1097/00006454-199702000-00021  0.68
1996 Oermann CM, Moore RH. Foolers: things that look like pneumonia in children. Seminars in Respiratory Infections. 11: 204-13. PMID 8883178  0.68
Show low-probability matches.